Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELNK
1051
DELISTED
EarthLink Holdings Corp.
ELNK
| $8.93M | 0.02% |
1,191,611
-1,398,839
| -54% | -$8.48M |
|
|
ONCE
1052
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $8.88M | 0.02% |
+147,320
| New | +$9.74M |
|
|
LOGM
1053
DELISTED
LogMein, Inc.
LOGM
| $8.83M | 0.02% |
+136,868
| New | +$8.58M |
|
1054
Pediatrix Medical
MD
$2.16B
| $8.82M | 0.02% |
119,045
-436,261
| -79% | -$31.4M |
|
|
DGI
1055
DELISTED
DigitalGlobe Inc.
DGI
| $8.8M | 0.02% |
316,668
+163,691
| +107% | +$5.17M |
|
|
FLIR
1056
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $8.79M | 0.02% |
285,038
-693,029
| -71% | -$21.5M |
|
1057
Century Aluminum
CENX
$4.32B
| $8.77M | 0.02% |
840,765
+405,354
| +93% | +$5.16M |
|
1058
QuidelOrtho
QDEL
$994M
| $8.77M | 0.02% |
381,897
+107,782
| +39% | +$2.51M |
|
|
TVRD
1059
Tvardi Therapeutics
TVRD
$23.7M
| $8.76M | 0.02% |
20,023
+13,801
| +222% | +$5.33M |
|
1060
CALL
Illumina
ILMN
$33.7B
| $8.73M | 0.02% |
+41,120
| New | +$8.03M |
|
1061
Alexandria Real Estate Equities
ARE
$9.3B
| $8.71M | 0.02% |
99,639
+21,037
| +27% | +$1.95M |
|
1062
ITT
ITT
$18.3B
| $8.69M | 0.02% |
207,621
-265,863
| -56% | -$11.1M |
|
|
LMNX
1063
DELISTED
Luminex Corp
LMNX
| $8.68M | 0.02% |
503,046
-443,702
| -47% | -$7.43M |
|
1064
Trinity Industries
TRN
$2.37B
| $8.68M | 0.02% |
456,082
-464,776
| -50% | -$10.4M |
|
1065
W.W. Grainger
GWW
$62.3B
| $8.67M | 0.02% |
+36,633
| New | +$8.88M |
|
1066
Gray Television
GTN
$507M
| $8.66M | 0.02% |
552,540
+10,364
| +2% | +$152K |
|
1067
Huntsman Corp
HUN
$1.68B
| $8.65M | 0.02% |
392,175
-1,505,306
| -79% | -$34.1M |
|
|
DHC
1068
Diversified Healthcare Trust
DHC
$1.94B
| $8.65M | 0.02% |
+497,518
| New | +$9.86M |
|
1069
PUT
Brinker International
EAT
$10.9B
| $8.65M | 0.02% |
+150,000
| New | +$8.59M |
|
1070
Akamai
AKAM
$15.2B
| $8.63M | 0.02% |
+123,597
| New | +$9.17M |
|
1071
Berkshire Hathaway Class A
BRK.A
$1.08T
| $8.6M | 0.02% |
42
+3
| +8% | +$644K |
|
1072
Ameris Bancorp
ABCB
$5.77B
| $8.6M | 0.02% |
339,877
+234,662
| +223% | +$6.02M |
|
1073
Revvity
RVTY
$13.7B
| $8.58M | 0.02% |
162,995
-194,530
| -54% | -$10.1M |
|
1074
Marten Transport
MRTN
$1.2B
| $8.52M | 0.02% |
981,678
+937,610
| +2,128% | +$8.52M |
|
1075
State Street SPDR S&P Regional Banking ETF
KRE
$4.06B
| $8.51M | 0.02% |
192,670
+50,267
| +35% | +$2.14M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.